incretin mimetic agents glp 1 receptor agonists Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus GLP-1-based therapies for type 2
Description
What Patients Need to Know Navigating side effects and knowing when to seek help can greatly improve your experience with GLP-1 medications
ColonBroom GLP-1 Booster is a dietary supplement, not a medication
PMID: 24762441
Exendin has a short half-life
JAMA 303:14101418 Pratley RE, Nauck M, Bailey T et al (2010) Liraglutide vs sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
